(OCUP) – Litigation
-
Ocuphire Pharma (OCUP) Granted Two New U.S. Patents Covering Late-Stage Drug Candidate Nyxol, Including for Treatment of Presbyopia
-
Ocuphire Pharma (OCUP) Announces Expansion of Global Patents for Nyxol® and $1.7 Million NIH Grants for APX3330 Program
Back to OCUP Stock Lookup
